march, 2023

06marAll Day08EUROCLONALITY WORKSHOP: ‘CLONALITY ASSESSMENT IN PATHOLOGY’

Event Details

Clonality testing is an established tool in the diagnosis of malignant lymphomas. With the introduction the IClonality testing is an established tool in the diagnosis of malignant lymphomas. Between 5-15% of samples submitted to pathology laboratories which are suspected to be malignant lymphomas can benefit from clonality testing, provided that this is performed in laboratories with sufficient expertise. With the introduction the IG/TR clonality assays by the BIOMED-2 group in 2003, a major step in standardization and quality improvement was set. Many laboratories throughout the world introduced the technology, resulting in questions on pitfalls in technique and the interpretation of the results.

Time

march 6 (Monday) - 8 (Wednesday)

Reacties zijn gesloten.

X